Education
About Us
Working with TipRanks
Follow Us
Michael Shetzline Insider Profile
4 Followers
Michael Shetzline, SVP, CMO, Head-Res&Drug at Ironwood Pharma, holds 521.42K shares in Ironwood Pharma (Ticker: IRWD). Most recently, Michael Shetzline Sold 15,570 shares of Ironwood Pharma on Feb 25, 2026 for an estimated value of $59.32K.
Michael Shetzline Ironwood Pharma (IRWD)SVP, CMO, Head-Res&Drug
Ironwood Pharma (IRWD)
SVP, CMO, Head-Res&Drug
Ranked #17,937 out of 106,131 Corporate Insiders
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
+17.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Shetzline's holdings
Insider Roles
SVP, CMO, Head-Res&Drug
Roles that Michael Shetzline holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael Shetzline
Michael Shetzline's Trading History
List of latest transactions for each holding click on a transaction to see Michael Shetzline's performance on stock
You May Also Like
Michael Shetzline insider profile FAQ
What is the percentage of profitable transactions made by Michael Shetzline?
The percentage of profitable transactions made by Michael Shetzline is 67%.
What is the average return per transaction made by Michael Shetzline?
The average return per transaction made by Michael Shetzline is 17.30%.
What stocks does Michael Shetzline hold?
Michael Shetzline holds: IRWD stocks.
What was Michael Shetzline’s latest transaction?
Michael Shetzline latest transaction was an Informative Sell of $59.32K.
What was Michael Shetzline's most profitable transaction?
Michael Shetzline’s most profitable transaction was an Informative Sell of IRWD stock on May 22, 2024. The return on the trade was 90.40%.
What is Michael Shetzline's role in Ironwood Pharma?
Michael Shetzline's role in Ironwood Pharma is SVP, CMO, Head-Res&Drug.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.